Cleared Traditional

K051825 - COGNITRACE (FDA 510(k) Clearance)

Sep 2005
Decision
69d
Days
Class 2
Risk

K051825 is an FDA 510(k) clearance for the COGNITRACE. This device is classified as a Full-montage Standard Electroencephalograph (Class II - Special Controls, product code GWQ).

Submitted by Eemagine Medical Imaging Solutions GmbH (Deer Field, US). The FDA issued a Cleared decision on September 12, 2005, 69 days after receiving the submission on July 5, 2005.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations.

Submission Details

510(k) Number K051825 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2005
Decision Date September 12, 2005
Days to Decision 69 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GWQ - Full-montage Standard Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations